Who owns the XERISOL trademark?

The XERISOL trademark is owned by Xeris Pharmaceuticals, Inc..

What is the serial number for XERISOL?

The USPTO serial number for XERISOL is 87450263.

What is the registration number for XERISOL?

XERISOL is registered under USPTO registration number 0.

XER

USPTO Trademark Record

ABANDONED

XERISOL

Q: What class is the XERISOL trademark registered in?

The XERISOL trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 87450263·Reg 0·Filed May 15, 2017

Owner Xeris Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

XERISOL (Serial No. 87450263), Registration No. 0, is a abandoned US trademark filed on May 15, 2017 by Xeris Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

XERISOL (Reg. #0) is an abandoned US trademark that was filed in 2017 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 15, 2017

SERIAL

87450263

REG#

Owner

Applicant

Xeris Pharmaceuticals, Inc.

Entity

Corporation

State

Address

180 N LaSalle Street, Suite 1810, Chicago, IL, 60601

Country

Attorney

NameTracy-Gene G. Durkin

Law firm

Tracy-Gene G. Durkin Sterne, Kessler, Goldstein & Fox P.L.L.C.

Docket

4605.0590000

Address

1100 New York Avenue, NW, Washington, DC 20005, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateMay 15, 2017

Serial Number87450263

Registration No.0

Status DateJan 11, 2021

Published for OppositionOct 10, 2017

Mark TypeStandard characters

Attorney Docket4605.0590000

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2017

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

46 events

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Jun 23, 2022

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

May 19, 2022

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jan 11, 2021

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

ABANDONMENT - NO USE STATEMENT FILED

Jan 11, 2021

ABANDONMENT - NO USE STATEMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 25, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 5 GRANTED

Jun 24, 2020

SOU EXTENSION 5 GRANTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 23, 2020

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 5 FILED

Jun 04, 2020

SOU EXTENSION 5 FILED

SOU TEAS EXTENSION RECEIVED

Jun 04, 2020

SOU TEAS EXTENSION RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 22, 2020

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

May 22, 2020

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

May 22, 2020

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

May 22, 2020

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

May 22, 2020

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 05, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 4 GRANTED

Dec 03, 2019

SOU EXTENSION 4 GRANTED

SOU EXTENSION 4 FILED

Dec 03, 2019

SOU EXTENSION 4 FILED

SOU TEAS EXTENSION RECEIVED

Dec 03, 2019

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 06, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 3 FILED

Jun 04, 2019

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Jun 04, 2019

SOU EXTENSION 3 GRANTED

SOU TEAS EXTENSION RECEIVED

Jun 04, 2019

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 02, 2018

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Oct 31, 2018

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Oct 31, 2018

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Oct 31, 2018

SOU EXTENSION 2 GRANTED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jun 27, 2018

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jun 27, 2018

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

ASSIGNED TO EXAMINER

May 31, 2018

ASSIGNED TO EXAMINER

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 12, 2018

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

May 10, 2018

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 GRANTED

May 10, 2018

SOU EXTENSION 1 GRANTED

SOU EXTENSION 1 FILED

May 10, 2018

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 05, 2017

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 10, 2017

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Oct 10, 2017

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 20, 2017

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 05, 2017

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Aug 21, 2017

ASSIGNED TO LIE

EXAMINERS AMENDMENT -WRITTEN

Aug 21, 2017

EXAMINERS AMENDMENT -WRITTEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Aug 21, 2017

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT E-MAILED

Aug 21, 2017

EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Aug 21, 2017

EXAMINER'S AMENDMENT ENTERED

ASSIGNED TO EXAMINER

Aug 14, 2017

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 19, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 18, 2017

NEW APPLICATION ENTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

XER

XERISOL

98677670

Xeris Pharmaceuticals, Inc.

PENDING

XERISOL

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Xeris Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Tracy-Gene G. Durkin

Resources

Company